Medallion Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.85K Hold
5
– – ﹤0.01% 969
2026
Q2
$1.8K Sell
5
-123
-96% -$37.6K ﹤0.01% 981
2026
Q1
$32.1K Hold
128
– – 0.01% 561
2025
Q4
$35.2K Buy
128
+45
+54% +$12.3K 0.01% 526
2025
Q3
$21.8K Buy
83
+10
+14% +$2.43K 0.01% 620
2025
Q2
$16K Hold
73
– – 0.01% 663
2025
Q1
$16.3K Hold
73
– – 0.01% 608
2024
Q4
$16.3K Hold
73
– – 0.01% 593

Other funds holding WST

Medallion Wealth Advisors's WST Position: Q3 2026 in Review

Medallion Wealth Advisors held its West Pharmaceutical (WST) position steady in Q3 2026 at 5 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Medallion Wealth Advisors first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $35.2K in Q4 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Medallion Wealth Advisors held 5 shares of West Pharmaceutical worth $1.85K as of Q3 2026.
  • Medallion Wealth Advisors left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q3 2026, its #969 holding.
  • Medallion Wealth Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
  • Medallion Wealth Advisors's West Pharmaceutical position peaked at $35.2K in Q4 2025.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.